National Bank of Canada
AMED

National Bank of Canada’s Amedisys AMED Stock Holding History

National Bank of Canada’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-97,052
Closed -$9.55M – 2840
2025
Q2 		$9.55M Buy
97,052
+20,565
+27% +$1.95M 0.01% 796
2025
Q1 		$7.08M Buy
76,487
+2,087
+3% +$192K 0.01% 816
2024
Q4 		$6.75M Buy
74,400
+18,808
+34% +$1.73M 0.01% 900
2024
Q3 		$5.37M Buy
55,592
+30,213
+119% +$2.95M 0.01% 831
2024
Q2 		$2.45M Sell
25,379
-49,005
-66% -$4.55M ﹤0.01% 897
2024
Q1 		$7.1M Sell
74,384
-68,050
-48% -$6.38M 0.01% 700
2023
Q4 		$13.5M Buy
142,434
+70,100
+97% +$6.55M 0.02% 496
2023
Q3 		$6.79M Buy
72,334
+59,702
+473% +$5.52M 0.01% 714
2023
Q2 		$1.15M Buy
12,632
+11,952
+1,758% +$981K ﹤0.01% 1108
2023
Q1 		$50K Buy
680
+420
+162% +$36.3K ﹤0.01% 1716
2022
Q4 		$21.7K Sell
260
-4,931
-95% -$445K ﹤0.01% 1982
2022
Q3 		$508K Buy
+5,191
New +$619K ﹤0.01% 1161

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

National Bank of Canada's AMED Position: Q3 2025 in Review

National Bank of Canada sold out of Amedisys (AMED) in Q3 2025, closing a stake of 97,052 shares — an estimated $9.55M sold.

National Bank of Canada first reported a position in AMED in Q3 2022 and held it in 12 quarters. The position peaked at $13.5M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • National Bank of Canada reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • National Bank of Canada sold 97,052 Amedisys shares in Q3 2025, an estimated $9.55M.
  • National Bank of Canada first reported a position in Amedisys in Q3 2022 and held it in 12 quarters.
  • National Bank of Canada's Amedisys position peaked at $13.5M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on National Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.